This inventor holds 2 USPTO granted patents. Top assignee: King Abdulaziz University. Active years: 2018-2019.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2018-2019
Title: Innovator Nahid H Hajrah: Pioneering Cancer Treatment and Nanotechnology
Introduction
Nahid H Hajrah is a prominent inventor based in Jeddah, Saudi Arabia. She has made significant contributions to the fields of pharmaceuticals and nanotechnology. With a total of 2 patents, her work focuses on innovative solutions for cancer treatment and advanced methods for protein immobilization.
Latest Patents
One of her latest patents is a pharmaceutical composition for treating cancer, which includes an anticancer compound named isopicrinine, isolated from a plant. This composition may also contain a salt, an analog, a derivative, and/or the prodrug of isopicrinine. The patent discloses a method of treating cancer using this pharmaceutical composition, as well as a method for extracting isopicrinine.
Another notable patent is a method for preparing chitosan-coated magnetic nanoparticles for protein immobilization. This method involves forming ferrous ferric oxide (FeO) nanoparticles through co-precipitation and subsequently coating them with chitosan in the presence of glutaraldehyde. The resulting chitosan-coated ferric oxide nanoparticles can be utilized to immobilize proteins or other biomolecules.
Career Highlights
Nahid H Hajrah is affiliated with King Abdulaziz University, where she continues to advance her research and innovations. Her work has garnered attention for its potential impact on cancer treatment and biotechnological applications.
Collaborations
She collaborates with esteemed colleagues, including Jamal Sabir M Sabir and Abdullah Yousef Obaid, contributing to a dynamic research environment.
Conclusion
Nahid H Hajrah exemplifies the spirit of innovation in the fields of pharmaceuticals and nanotechnology. Her patents reflect her commitment to developing groundbreaking solutions that address critical health challenges.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
